The DOI matches its Crossref record.
Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study
Abstract
Summary: objective We aimed to study the effect of biosynthetlc growth hormone (GH) replacement In growth hormone deficient adults. design We performed a double‐blind placebo‐controlledcross‐over study of 6 months biosynthetic GH, replacement and 6 months placebo separated by a 1‐month'swashout period. patients Fourteen growth hormone deficient adults were studied. measurements We measured total body weight, percentage fat mass, lean body mass, muscle volume, exercise capacity, maximum oxygen consumption, muscle strength, bone mineral content, a number of biochemical parameters, IGF‐I, GH antibodies andpsychological well‐being. results Total body weight remained unchanged, but lean body mass increased (before GH mean ± SEM 49·8±5·5, after 53·4±5·6 kg; placebo before 51·2±5·4, after 50·4±5·1 kg; P < 0·05 and fat mass decreased (before GH 21·5±4·1, after 19·3±4·3, placebo before 19·3±4·0, after 22·5±4·5 kg; p < 0·05). Thigh muscle volume increased: (before GH 94·1±7·7, after 99·5±8·4 ml; placebo before 99·3±8·6, after 95·4±7·8 ml/0·8 mm computerized tomographic slice; P < 0·05). Exercise capacity increased (before GH 174·15, after 199·18·9 watts; placebo before 162·5±2·3, after 154·19·8 watts; P < 0·05), as did maximum oxygen consumption (before GH 1·93±0·2, after 2·17±0·2 I/m; placebo before 1·92±0·3, after 1·98±0·2 I/m; P < 0·05). There was no change in quadriceps muscle strength. Alkaline phosphatase increased (before GH 87·5 (32–158), after 106·0 (49–179) U/l; placebo 98·5 (50–145), after 72·0 (40–111) U/l; P < 0·05) without a change in the spinal bone density. IGF‐I increased (before GH 62 (36–97), after 216 (62–362) μ g/l; placebo before 59 (52–112), after 60·5 (38–94) μ g/l; P < 0·05). Carbohydrate tolerance remained unchanged as did fasting lipids, serum sodium, potassium, urea, calcium, phosphate and liver transaminases. Psychological well‐being remained unchanged. No growth hormone antibodies were detected before or after GH treatment. conclusions GH alters the body composition of growthhormone deficient adults and leads to improved exercisecapacity; alkaline phosphatase activity increases butwithout a change in spinal bone density, and carbohydratetolerance remains unaltered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414
The growth hormone deficiency syndrome in adults
Cuneo, R. C., Salomon, F., McGauley, G. A., & Sönksen, P. H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02347.x · Cited by 375
Maison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030840 · Cited by 362
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257
Growth Hormone and Cardiovascular Risk Factors
Gola, M., Bonadonna, S., Doga, M., & Giustina, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0545 · Cited by 135
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency
Evans, M., Davies, Goodfellow, Rees, & Scanlon (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00671.x · Cited by 129
Gelding, S. V., Taylor, N. F., Wood, P. J., Noonan, K., Weaver, J. U., Wood, D. F., & Monson, J. P. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3641180.x · Cited by 124
Widdowson, W. M., & Gibney, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1239 · Cited by 107
Which adults develop side-effects of growth hormone replacement?
Holmes, S. J., & Shalet, S. M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01908.x · Cited by 101
Impact of the GH-cortisol ratio on the age-dependent changes in body composition
Nass, R., & Thorner, M. O. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00022-9 · Cited by 58
Mossberg, K. A., Durham, W. J., Zgaljardic, D. J., Gilkison, C. R., Danesi, C. P., Sheffield-Moore, M., Masel, B. E., & Urban, R. J. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4552 · Cited by 44
Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH‐deficient adults
Clanget, C., Seck, T., Hinke, V., Wüster, C., Ziegler, R., & Pfeilschifter, J. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01284.x · Cited by 42
Valk, N. K., Erdtsieck, R. J., Algra, D., Lamberts, S. W. J., & Pols, H. A. P. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02038.x · Cited by 28
Metadata
- Authors
- Whitehead, H. M., Boreham, C., Mcllrath, E. M., Sheridan, B., Kennedy, L., Atkinson, A. B., & Madden, D. R.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1992-01
- Volume
- 36
- Issue
- 1
- Pages
- 45-52
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2000607618
- Cited by
- 377
- References
- 0
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.